Good Manufacturing Practices
Good Manufacturing Practices (GMP) are the regulatory and operational controls that ensure pharmaceuticals, biologics, cell therapies, and sterile devices are consistently produced to defined quality, potency, and sterility standards. GMP integrates facility design, environmental monitoring, validated processes, robust documentation, and supply-chain integrity to support safe, deployable medical products for military and civilian use.
Technical Challenges
Scaling aseptic manufacturing for small-batch, rapid-response biologics and autologous cell therapies.
Ensuring sterility and potency when evacuations are delayed or care is prolonged in austere environments.
Maintaining cold chain and supply-chain integrity for temperature-sensitive products in deployed logistics.
Validating novel modalities (e.g., viral vectors, engineered cell therapies) under compressed timelines and limited facility access.
Emerging Opportunities
Mobile, modular GMP suites capable of forward, near‑patient production with validated aseptic processing.
Rapid-release microbiological and potency assays that shorten lot-release while assuring safety.
Standardized, ruggedized single-use systems and closed-manufacturing platforms for field use.
Integrated digital batch records and traceability tools optimized for distributed manufacturing and DoD logistics.
Current and Emerging Technologies in Good Manufacturing Practices
Modular and Mobile GMP Cleanrooms
Prefabricated ISO-class modular cleanrooms and mobile suites enable forward manufacturing and on‑site fill/finish operations with environmental control and validated workflows.
Single-Use and Closed-System Manufacturing
Disposable bioreactors, tubing assemblies, and closed connectors reduce cross-contamination risk, accelerate changeover, and simplify cleaning qualifications in constrained settings.
Rapid Microbiological and Potency Assays
Molecular assays, ATP-based viability tests, and accelerated sterility methods shorten lot-release timelines and support faster deployment of critical therapeutics.
Continuous and Small‑Batch Manufacturing
Continuous processing and micro-batch platforms enable efficient production of drugs and APIs with reduced footprint and real-time quality control (PAT).
Digital Quality Systems and Supply-Chain Traceability
Electronic batch records, manufacturing execution systems, and blockchain-enabled traceability improve audit readiness and provide end-to-end visibility critical for DoD logistics.
Point-of-Care and On‑Demand Biomanufacturing
Portable platforms for cell therapy, autologous grafts, or antigen production at the point of need support prolonged and distributed care scenarios where timely evacuation is not possible.
Importance to Military Medicine
Combat Casualty Care and Safety
GMP prevents contamination and ensures product potency for life‑saving interventions (hemostatics, blood products, antibiotics) used in polytrauma and blast injuries.
Prolonged and Distributed Care
Validated, small-batch manufacturing and rapid-release testing enable on-site therapies when evacuation is delayed or care is delivered in austere settings.
Readiness and Rapid Response
GMP-capable infrastructure supports surge production for outbreaks, biodefense countermeasures, and rapid fielding of novel therapeutics to maintain force readiness.
Logistics and Sustainment
Supply-chain integrity, lot traceability, and standardized QC reduce risk in distributed supply networks and austere resupply chains.
Alignment with the MTEC Mission
Directly advances MTEC’s DoD-focused mission by accelerating translation of deployable medical technologies that meet regulatory and operational quality standards.
Supports cross-disciplinary projects spanning combat casualty care, infectious disease, and regenerative medicine where GMP is required for clinical readiness.
Enables rapid, dual-use solutions that translate from research to field-capable products benefiting warfighters and civilians.
Encourages consortium collaboration among academia, industry, and military stakeholders to address validation, supply-chain, and manufacturing challenges.
Dual-Use (Military + Civilian) Applications
Combat casualty therapeutics and sterile devices—ensuring safe on‑site availability of hemostatics, wound care, and implants.
Biodefense and outbreak response—rapid GMP production of vaccines, antivirals, and diagnostics for force health protection and civilian benefit.
Regenerative therapies and cell-based products manufactured under controlled conditions for battlefield reconstruction and functional recovery.
Dual-use civilian applications including surge vaccine manufacturing, sterile diagnostics, and rapid-release therapeutics for public health emergencies.
Explore MTEC Members with Good Manufacturing Practices Capabilities
MTEC members bring unique strengths—regulated manufacturing expertise, modular cleanroom design, rapid assay development, and DoD-centric logistics experience—accelerating transition from prototypes to GMP-ready products.
Explore member profiles to identify partners with validated GMP facilities, mobile manufacturing solutions, and capabilities in accelerated lot release and distributed production tailored to military needs.
48 Members with Good Manufacturing Practices capabilities.
SIMETRI is a woman-and-minority owned small business based in Winter Park, Florida, specializing in modeling, simulation, and training technologies. Founded in 2009, the company focuses on delivering innovative products and services that enhance the human experience and improve client outcomes through advanced training and program management analysis.
Nanohmics Inc. is a Texas-based research and development company founded in 2002, specializing in the applied sciences of light, molecule, and advanced material interactions. The company focuses on designing and developing smart technology solutions that enhance product, technology, or system performance across various industries. With a multidisciplinary team of scientists and engineers, Nanohmics integrates advanced materials and state-of-the-art instrumentation engineering to create custom-engineered sensing technologies and platforms. Their mission is to accelerate client success through innovative product development, providing solutions for detection, surveillance, electro-optic imaging, performance characterization, environment awareness, and energy conversion applications.
BioPharma Connections is an independent, woman-owned consulting firm founded in San Francisco in 2007, providing strategic business development, technical operations, regulatory, product development, and commercialization support to the life sciences industry. Serving pharmaceutical, biotechnology, medical device, and diagnostic companies globally, the firm specializes in facilitating connections between organizations, service providers, CROs, CDMOs, and investors—guiding clients from concept to commercialization, with deep expertise in regulatory compliance, emerging technologies, and diverse therapeutic areas.
Harmac is a global contract design and manufacturing organization specializing in single-use medical devices. With over four decades of experience, Harmac provides comprehensive services including product design and development, advanced manufacturing, automation, value engineering, quality assurance, and packaging and sterilization. The company is known for its operational excellence, regulatory compliance, and commitment to sustainability and community engagement. Harmac operates facilities across the United States, Ireland, and Mexico, supporting customers worldwide and across a range of clinical applications. ISO 13485 Certified and FDA Registered.
Clinical Research Strategies (CRS) is a Pittsburgh-based contract research organization and executive management consultancy dedicated to improving the performance of start-up and mid-size life sciences companies. With a focus on instilling fiscal discipline and reducing risks in clinical development, corporate affairs, and quality assurance programs, CRS provides tailored consulting and staffing solutions to navigate the complexities of regulatory pathways and ensure successful product launches. CRS is also committed to leveraging advancements in artificial intelligence and machine learning to enhance clinical research and regulatory processes.
Ease Healthcare (a registered DBA of MPS Medical, Inc.) is committed to advancing next-generation military medicine by accelerating access to clinically validated diagnostic tools, monitoring devices, and health and wellness technologies. As a trusted commercialization partner and distributor, the company empowers providers, organizations, and individuals with advanced solutions that support early detection, timely intervention, and improved health outcomes in both civilian and military settings. With a mission to make cutting-edge science and technology accessible to all, Ease Healthcare focuses on addressing critical health challenges such as 02 delivery, cancer, and cardiovascular disease —areas that directly impact force readiness and resilience. The company’s vision is to break barriers in healthcare by delivering innovative medical solutions that are affordable, accessible, and simple to use, regardless of economic or geographic limitations. In addition to bringing transformative technologies to market, Ease Healthcare provides turnkey services for medical device manufacturing and distribution, guiding partners from product development through regulatory compliance and successful deployment. By combining technical expertise with a dedication to accessibility, Ease Healthcare supports the Department of Defense’s priorities in preparing and protecting service members with next-generation healthcare solutions.
EmergingDx is dedicated to inventing, developing, and commercializing emerging technologies and products aimed at improving the quality of the human condition while positively impacting the environment and society. The company comprises a diverse team of world-class scientists, engineers, product designers, and business leaders with a proven track record of innovation and successful technology transition.
Simbex is a leading partner in medical device and consumer health product design and development, recognized for transforming complex ideas into commercially successful solutions. With a multidisciplinary team, Simbex excels in engineering, product design, software, data analytics, and commercialization strategy, supporting innovators from concept to market. Their mission is to deliver impactful medical devices and consumer health products that improve health outcomes and quality of life. Simbex is known for its holistic approach, deep regulatory expertise, and commitment to innovation and excellence in the health technology sector. The company is also active in thought leadership, regularly publishing regulatory and reimbursement updates, and hosting educational webinars for the MedTech community. Simbex maintains a robust Quality Management System compliant with ISO 13485 and FDA 21 CFR 820, ensuring high standards in product development. The company is also committed to supporting diversity in MedTech, including initiatives for women in the sector. Simbex's leadership and advisory team bring decades of experience in biomedical engineering, commercialization, regulatory affairs, and technology innovation, further strengthening its position as a trusted partner in the MedTech ecosystem.
Prolucid Technologies Inc. specializes in custom software development for highly regulated industries, including medical and nuclear sectors. With over 17 years of experience and more than 1200 projects completed, Prolucid delivers robust, secure, and compliant software solutions. The company is ISO 13485 certified for medical software and adheres to CSA N299.1 and ISO 9001 standards for nuclear applications. Prolucid offers end-to-end services from project definition and planning to design, development, verification, and ongoing support, leveraging advanced technologies such as AI, ML, computer vision, and cloud infrastructure.
Solventum is a healthcare company dedicated to enabling better, smarter, and safer healthcare solutions. With a legacy of innovation, Solventum focuses on improving patient outcomes through advanced medical technologies, oral care solutions, health information technology, and purification and filtration systems.
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue. The company aims to restore people's bodies and their self-belief by using technology to take the limits off living. With a commitment to medical education and improving patient outcomes, Smith+Nephew operates in over 100 countries and is dedicated to sustainability and community health. Their purpose is to promote health and wellbeing, not just through their products but also by ensuring a positive impact on society and the environment. Smith+Nephew is also committed to increasing diversity within the medical device industry through initiatives like the Orthopaedics for All global advisory board.
CellBios is a biotechnology company specializing in the design, development, and manufacturing of single-use bioprocessing and medical device solutions for healthcare, biotechnology, and regenerative medicine sectors. The company operates GMP and ISO-certified cleanroom facilities, offering a comprehensive portfolio of cryopreservation products, bioreactors, fluid management systems, advanced packaging, and specialty devices. By leveraging expertise in extrusion, molding, assembly, sterilization, quality control, and regulatory compliance, CellBios provides customized, scalable solutions to support blood transfusion, cell and gene therapy, biologics manufacturing, and clinical workflows.
Alira Health is a global consulting and clinical services company that aims to humanize healthcare and life sciences through innovative technologies and expert guidance. They focus on improving patient outcomes by integrating patient voices into the development of treatments and enhancing care quality across the healthcare ecosystem.
Hatch PD specializes in product design and development, offering a comprehensive range of services from concept to consumer. With a focus on innovation, efficiency, and quality, Hatch collaborates with clients to transform ideas into market-ready products while ensuring seamless integration of design and manufacturing processes. Their all-in-one approach integrates hardware, software, and firmware development, reducing time to market and enhancing product quality.
SASRAC provides trusted, authoritative research and consulting services focused on occupational and environmental safety and health challenges. With expertise in developing hearing damage risk criteria, measuring impulsive noises, evaluating hearing protector performance, and creating wireless audiometric testing technologies, SASRAC has been at the forefront of applied research since the 1970s. Founded by experienced professionals from the USAF and CDC/NIOSH, SASRAC is dedicated to advancing technologies in audiology, bioacoustics, and hearing conservation.
Southwest Research Institute (SwRI) is a nonprofit research and development organization that provides independent, premier services to government and industry clients. Founded in 1947, SwRI is committed to advancing science and technology to benefit humanity, focusing on innovative solutions that improve human health and safety. With a diverse range of technical divisions, SwRI addresses complex challenges in various fields including mechanical engineering, materials, aerospace, automotive, biomedical, and more.

Moberg Analytics
Moberg Analytics – Advanced Brain Monitoring & Critical Care Informatic
Moberg’s platform unifies brain monitoring data for faster, precise treatment of severe brain injuries in military and civilian care.
University of California San Francisco
TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness
TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.
Arizona State University
ASU Crosscutting Technologies to Enhance Military Medical Readiness and Resilience
Dr. Rachel Cassalia leads MTEC-supported efforts at ASU to shift military health from reactive care to proactive readiness through data-driven prevention.
University of Pittsburgh
Topical Metformin Lotion for Tendinopathy Prevention
University of Pittsburgh study shows topical metformin prevents overuse tendon injury. This work was sponsored through MTEC project 22-02-MPAI-014.